Startup profile for Eligible: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Eligible funding, valuation and investors

Eligible is an Andreessen Horowitz (a16z) portfolio company currently tracked as part of our hot a16z coverage set.

Keep track of Eligible

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Seed

$2.3M · 2014

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$2.3M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

Stage not recorded

Investors in latest funding

Other: Andreessen Horowitz

Sources: latest funding Last verified: 2026-07-25

Overview

Eligible provides REST APIs for healthcare insurance billing — eligibility verification, claims submission, and payment status tracking. Founded 2011 by Katelyn Gleason, it abstracts X12 EDI into JSON for digital health startups embedding billing. a16z and Y Combinator among backers. Raised $2.3M per 2014 SEC filing for eligibility API expansion.

Why Eligible is interesting

Eligible appears on a16z’s public investment list. We include it because a16z-backed companies are disproportionately “on fire” for follow-on capital, hiring, and category creation — useful for founders mapping competitors and investors mapping active theses (AI, American Dynamism, crypto, bio, fintech).

Product & use cases

Insurance billing APIs — eligibility, claims, remittance, and payment status for healthcare apps via REST/JSON.

  • Real-time insurance eligibility checks in digital health apps
  • Claims submission and status tracking via API
  • Replacing legacy clearinghouse integrations for startups

Key facts

  • Co-investors: no additional institutional investors disclosed in public sources reviewed 2026-07-24 (early angels/Fresco Capital named in press; not in VCT directory)

Funding history (newest first)

Investors in our directory

Funds linked from Eligible's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: Eligible differentiates through focused product scope and a16z-backed GTM in its category — see competitors for tradeoffs vs. incumbents.

Eligible operates in a competitive category where incumbents have distribution but startups win on workflow fit. See named competitors for honest better/worse notes; we do not invent market share.

  • Change Healthcare (Optum) incumbent

    Clearinghouse incumbent; Eligible API-first for developers.

  • Stripe (healthcare) adjacent

    Payments infra; Eligible insurance-specific.

Notable stories

  • Co-investors: no additional institutional investors disclosed in public sources reviewed 2026-07-24 (early angels/Fresco Capital named in press; not in VCT directory)

Industries

Healthtech Fintech Developer Tools

FAQs about Eligible

Practical answers founders, operators, and investors typically search for.

Insurance billing APIs — eligibility, claims, remittance, and payment status for healthcare apps via REST/JSON.
Andreessen Horowitz (/fund/andreessen-horowitz) among disclosed investors. See fundraising rounds and investors[] for co-investors in our directory.
We track a16z-backed companies strategically relevant for founders mapping competitors and investors following active theses.
Stage: other; status: private.
See fundraisingRounds — amounts included only when verified in press or company announcements.
See competitors and competitiveAnalysis sections for named alternatives.
Profitability not publicly disclosed unless noted in highlights. Public companies: check SEC filings.
Tagged: healthtech, fintech, developer-tools.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.